Like most companies in 2020, Dexcom (NSDQ:DXCM) faced a number of challenges brought on by COVID-19, public unrest and more.
Dexcom chairman, president & CEO Kevin Sayer had to prioritize the health of his employees over all else, while also keeping patients safe and somehow managing to keep the diabetes giant rolling as a business.
“Anybody who says they’re prepared for something like this, they’re better than me,” Sayer told Medical Design & Outsourcing. “I think we’re just learning as we go.”
Get the full story at our sister site, Medical Design & Outsourcing.
